Fused heterocyclic compounds

Details for Australian Patent Application No. 2006241210 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Aso, Kazuyoshi; Gyorkos, Albert Charles; Corrette, Christopher Peter; Pratt, Scott Alan; Cho, Suk Young; Siedem, Christopher Stephen; Mochizuki, Michiyo

Agent Griffith Hack

Pub. Number AU-B-2006241210

PCT Pub. Number WO2006/116412

Priority 60/742,101 02.12.05 US; 60/675,113 27.04.05 US

Filing date 26 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 17 November 2011

International Classifications

C07D 235/24 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/04 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/12 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/18 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116412 Priority application(s): WO2006/116412

17 November 2011 Application Accepted

  Published as AU-B-2006241210

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006241219-Methods of treating atherosclerosis

2006241206-Compositions and methods for cancer immunotherapy